Various regulatory agencies emphasize on the biosimilarity data that at its core includes analytical data (both physico-chemical and functional) comparing the innovator product and intended biosimilar product. Having access to innovator analytical data range on some of the critical quality attributes (CQAs) is important for a biotech company to effectively develop process that would produce biosimilar molecule. Most companies put efforts in generating the innovator product quality data in-house, which is usually challenging. Biocognate would offer innovator product quality data package covering some of the CQAs, which would help the biosimilar developer to speed up their in-house product development timeline.